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PRELIMINARY AND SHORT REPORTS
TREATMENT OF SEVERE RHUS DERMATITIS WITH CORTICOTROPIN
OR CORTISONE*
MOETIMEE S. FALK, M.D.t, M. F. ALLENDE, M.D., AND JAMES H. BENNETT, M.D
Acute contact-type dermatitis due to poison oak (Rhus diversiloha) is common in the
Oakland-Berkeley area. In our experience the occurrence of severe generalized incapacitat-
ing dermatitis, sometimes with secondary pyoderma, is relatively frequent. It has been our
practice to hospitalize many of these patients to assure proper nursing care and prevent
further complications. Until recently the treatment employed consisted of the usual symp-
tom-relieving measures, viz, cool compresses (potassium permanganate or boric acid) to
the involved areas, "antipruritic" lotions, antibiotics parenterally where there was second-
ary infection, sedatives, occasionally Demerol ®, and antihistaminics (of doubtful value
in our experience except possibly for their soporific effect in some patients). Although these
measures probably shorten the duration of discomfort and incapacitation because the
spread of the dermatitis is limited and further complications are prevented, the patients
are usually miserably uncomfortable for several days.
Since July 1951, patients with rhus dermatitis of severe enough involvement to require
hospitalization have been treated with corticotropin (ACTH) or cortisone if there were no
obvious contraindieations (peptic ulcer, tuberculosis, diabetes mellitus, etc.). The dosage
schedules employed were essentially as follows:
A. Corticotropin: 25 mgm. every 6 hours first day, 20 mgm. every 6 hours second day,
15 mgm. every 6 hours third day.
B. Cortisone: 200 mgm. first day, 150 mgm. second day, 100 mgm. third day.
In Table I we have recorded our experience with 10 hospitalized patients selected at ran-
dom prior to our use of eorticotropin and cortisone. The average period of hospitalization
was 6.6 days, and the average duration of disability was 11.4 days.
Tn Table II, observations on 9 patients treated with eorticotropin or cortisone are re-
corded. In this group the average period of hospitalization was 3.3 days. The duration of
disability following onset of treatment would correspond with the period of hospitalization;
in several cases it was actually shorter since the patients were well enough to return to work
on the third day. Eight of the nine patients were relieved of the severe pruritus within
12—36 hours, and there was also a remarkable objective improvement in that the marked
edema and weeping "disappeared overnight." All but one of the patients were discharged
from the hospital after the three days of corticotropin or cortisone with instructions to
continue symptomatic treatment at home. The one failure may have been due to inadequate
dosage of ACTH. In some of the patients there was a recurrence of pruritus the day followS
ing discharge, hut in none was it nearly so severe as before. Even this may be prevented by
prescribing oral cortisone in a dosage of 25 mgm. two or three times daily for a few more
days. It is probable that many of these patients could have been treated entirely as out-
patients with equivalent doses of cortisone given orally. Most of them would have been
able to return to work within 48 hours.
On the basis of this limited study, we feel that cortieotropin or cortisone is probably the
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treatment of choice in severe acute contact dermatitis for patients in whom there is no con-
traindication to their administration. (The extremely short duration of treatment avoids the
development of side effects, and therefore answers criticisms which might be leveled at the
use of these hormones in the treatment of a self-limited disease.)
TABLE I
Date on ten patients with severe Rhus dermatitis treated with "symptom-relieving" measures
(control series)
DURATION DURATION OURAT1ON
PATIENT
ADMI55ION
INVOLVEMENT dEE KEY) COMPLICATIONS OFIIOSflT- OFDISA
1. E.R.W. 6 days F, A, N, C, Pyoderma arms 6 days 18 days
++++ Temp.102
2. R.W. 4 days F, N, C, Ab, B None 12 days 14 days
14&
3. MR. 14 days F, A, L, Pyoderma 4 days 10 days
159 +++
4. P.L. 7 days F, N, C, A, Secondary infection 10 days 15 days
37c? ++++
5. F.McB. 6 days A, L, V, Secondary infection 5 days 8 days
219 +++
6. 13.5. 3 days F, A, L, None 4 days 6 days
129 +++
7. G.G. 8 days F, A, C, Temp. 100 6 days 12 days
159 +++
S. B.H. 2 days F, N, A, Temp. 1001 8 days 11 days
149 ++++
9. 13W. 2 days F, N, A, L, None 6 days 8 days
309 ++++
10. TA. 5 days F, C, B, A. C, Temp. 1012 5 days 12 days++++
* Mean = 5.7 days.
t Mean = 6.6 days, median = 6 days, a =
t Mean = 11.4 days, median = 11.5 days.
Kin: A—upper extremities; Ab—abdomen; B—back; Bu—buttocks; C—chest; F—face;
C—genitalia; L—lower extremities; N—neck; Ph—pharynx; V—vulva; +++—moder-
ately severe involvement; ++++—very severe involvement.
5UMMARY
1. Experience in the treatment of severe incapacitating contact-type dermatitis with
the usual routine symptom relieving measures and with corticotropin or cortisone is com-
pared.
2. The rapid relief of symptoms and objective improvement, as well as the apparent
prevention of complications, in eight of nine patients treated with corticotropin or cortisone
suggests the value of these agents, when not contraindicated by other illnesses, in severe
acute contact-type dermatitis.
ADDENDUM
Since we submitted thispaper for publication Baldridge and Kligman reported the failure
of relatively large doses of cortisone to "affect the inducement, development, or elicitation
of experimental eczematous contact type dermatitis" in controlled experiments on guinea
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pigs (1). From their experiments they intimate that ACTH and cortisone are ineffective in
the treatment of contact-type dermatitis. We do not feel that this conclusion is warranted.
Our patients were not re-exposed to the offending agent after treatment was started.
It may well be that if patients with acute rhus dermatitis are re-exposed to the plant or its
oils while they are receiving corticotropin or cortisone, they would react very much as did
the experimental animals. If this is so, it means that the individual's sensitivity to the
agent and the capacity of his skin to react are unchanged. If, however, as in our small series,
the patients are not re-exposed to the agent and improve more rapidly than the control
group (subsidence of edema, vesiculation, pruritus) it indicates that corticotropin and
cortisone have some influence on the dermatitic process. We agree that carefully controlled
clinical evaluation of a larger series is needed.
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